Scripta Therapeutics

Oxford, United Kingdom

Scripta Therapeutics operates as a bio-tech company.

$12.0M raised

Nov 2025

Seed

Biotechnology Medical Therapeutics

Top Investors

YZR CapitalOxford Science EnterprisesParkwalk AdvisorsAlbionVCApollo Health Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scripta Therapeutics

How much funding has Scripta Therapeutics raised?

Scripta Therapeutics has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Scripta Therapeutics's investors?

Scripta Therapeutics's investors include YZR Capital, Oxford Science Enterprises, Parkwalk Advisors, AlbionVC, Apollo Health Ventures.

Where is Scripta Therapeutics headquartered?

Scripta Therapeutics is headquartered in Oxford, United Kingdom.

What does Scripta Therapeutics do?

Scripta Therapeutics operates as a bio-tech company.

What stage is Scripta Therapeutics at?

Scripta Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 13, 2025.

MLA

"Scripta Therapeutics — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/scripta-therapeutics. Accessed June 5, 2026.

APA

VCBacked. (2025). Scripta Therapeutics — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/scripta-therapeutics

Wikipedia (cite web)

{{cite web |title=Scripta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scripta-therapeutics |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 13, 2025.